Novo Nordisk

One Ozempic Pen and 4 disposable needles (1mg) Ozempic® (semaglutide) injection 1 mg is an injectable prescription medicine used: along with diet and exercise to improve blood sugar (glucose) in adults with...

1 Pen and 6 disposable needles Ozempic® (semaglutide) injection 0.25 mg / 0.5 mg is an injectable prescription medicine used: along with diet and exercise to improve blood sugar (glucose)...

This pen contains 3ml solution and is able to deliver doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg and 3.0 mg Saxenda® (liraglutide) is an injectable prescription medicine used...

The NovoFine® needle portfolio is an integral part of the Novo Nordisk delivery system, along with our diabetes medicines and pens. NovoFine® comes in different lengths and widths. 31G needles are...

Wegovy (semaglutide) is a prescription GLP‑1 receptor agonist indicated for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight‑related...

Wegovy 1 mg is a prescription glucagon‑like peptide‑1 (GLP‑1) receptor agonist pen used as the third step in the standard dose‑escalation schedule for chronic weight management. It is indicated for...

Wegovy 0.25 mg is a prescription glucagon‑like peptide‑1 (GLP‑1) receptor agonist used as the initial starting dose for chronic weight management. It is indicated for adults with obesity (BMI ≥30...

The Novofine 30G 8mm needle is a premium, ultra-thin insulin pen needle designed for comfortable, precise injections. Manufactured by Novo Nordisk—a global leader in diabetes care—this single needle combines exceptional...

Wegovy 1.7 mg is a prescription glucagon‑like peptide‑1 (GLP‑1) receptor agonist pen used as the fourth step in the standard 16‑week dose‑escalation schedule for chronic weight management. It is indicated...

Wegovy (semaglutide) is a prescription GLP‑1 receptor agonist for chronic weight management in adults and adolescents (12 years and older with body weight >60 kg) who have obesity (BMI ≥30...